Audrey Hemadou
Bordeaux, 33076, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
In Vivo Human Single-Chain Fragment Variable Phage Display-Assisted Identification of Galectin-3 as a New Biomarker of Atherosclerosis.
Journal: Journal of the American Heart Association
Published: September 27, 2021
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis.
Journal: International journal of molecular sciences
Published: March 25, 2021
Glioblastoma Immune Landscape and the Potential of New Immunotherapies.
Journal: Frontiers in immunology
Published: July 21, 2020
Development of anti-chloro 192 tyrosine HDL apoA-I antibodies for the immunodiagnosis of cardiovascular diseases.
Journal: Journal of immunological methods
Published: May 15, 2019
Multimodal molecular imaging of atherosclerosis: Nanoparticles functionalized with scFv fragments of an anti-αIIbβ3 antibody.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 06, 2018
Pacific Biosciences Sequencing and IMGT/HighV-QUEST Analysis of Full-Length Single Chain Fragment Variable from an In Vivo Selected Phage-Display Combinatorial Library.
Journal: Frontiers in immunology
Published: October 30, 2017
An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosis.
Journal: Scientific reports
Published: September 11, 2017
A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.
Journal: PloS one
Published: July 11, 2016
Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis.
Journal: Bioconjugate chemistry
Published: January 12, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026